BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24647008)

  • 1. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening.
    Sung JJ; Ng SC; Chan FK; Chiu HM; Kim HS; Matsuda T; Ng SS; Lau JY; Zheng S; Adler S; Reddy N; Yeoh KG; Tsoi KK; Ching JY; Kuipers EJ; Rabeneck L; Young GP; Steele RJ; Lieberman D; Goh KL;
    Gut; 2015 Jan; 64(1):121-32. PubMed ID: 24647008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance.
    Sung JJY; Chiu HM; Lieberman D; Kuipers EJ; Rutter MD; Macrae F; Yeoh KG; Ang TL; Chong VH; John S; Li J; Wu K; Ng SSM; Makharia GK; Abdullah M; Kobayashi N; Sekiguchi M; Byeon JS; Kim HS; Parry S; Cabral-Prodigalidad PAI; Wu DC; Khomvilai S; Lui RN; Wong S; Lin YM; Dekker E
    Gut; 2022 Nov; 71(11):2152-2166. PubMed ID: 36002247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asia Pacific consensus recommendations for colorectal cancer screening.
    Sung JJ; Lau JY; Young GP; Sano Y; Chiu HM; Byeon JS; Yeoh KG; Goh KL; Sollano J; Rerknimitr R; Matsuda T; Wu KC; Ng S; Leung SY; Makharia G; Chong VH; Ho KY; Brooks D; Lieberman DA; Chan FK;
    Gut; 2008 Aug; 57(8):1166-76. PubMed ID: 18628378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
    Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
    Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.
    Leuraud K; Jezewski-Serra D; Viguier J; Salines E
    Cancer Epidemiol; 2013 Dec; 37(6):959-67. PubMed ID: 24035240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Tuohy TM; Rowe KG; Mineau GP; Smith KR; Pimentel R; Wong J; Boucher K; Burt RW
    Gastroenterology; 2014 Oct; 147(4):814-821.e5; quiz e15-6. PubMed ID: 25042087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tests and investigations for colorectal cancer screening.
    Carroll MR; Seaman HE; Halloran SP
    Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
    Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
    J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.